The activin-class ligands activin A, growth differentiation factor 8 (GDF8), and GDF11—prominent activators of SMAD2/3-pathway signaling—are conspicuously upregulated in small pulmonary arteries in both experimental and human PAH (15). The gene discussed is SMAD2; the disease is pulmonary arterial hypertension.